EUVIMEDEUVIMED entdecken
Crossref

1,2,4-Triazine derivatives as agents for the prevention of AGE-RAGE-mediated inflammatory cascade in THP-1 monocytes: An approach to prevent inflammation-induced late diabetic complications

Humera Jahan, Priya Tufail, Shahbaz Shamim, Khalid Mohammed Khan, Michele Gennari, Marina Pizzi, M Iqbal Choudhary

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.113145 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Humera Jahan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karac…. Hauptthemen laut MEDLINE: Triazines, Glycation End Products, Advanced, Monocytes, Receptor for Advanced Glycation End Products. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Higher Education Commision, Pakistan, Higher Education Commission, Pakistan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Monocytes mainly contribute to the development and progression of vascular inflammatory conditions via the M1 polarization. The elevated levels of advanced glycation end products (AGEs) in diabetic environment lead to severe inflammation, and the release of pro-inflammatory mediators. This shifts the balance towards the pro-inflammatory state of monocytes. OBJECTIVE: The current study was aimed to determine the antiglycation activity of 1,2,4-triazine derivatives, and study of their molecular basis in regulating the AGEs-mediated inflammatory responses in THP-1 monocytes. METHODS: Primarily, the antiglycation activity of a series of 1,2,4-triazine derivatives was evaluated against MGO-AGEs in vitro. The toxicity of antiglycation compounds was determined by a metabolic assay, using human hepatocyte (HepG2) and monocyte (THP-1) cell lines. DCFH-DA probe was used to evaluate the antioxidant potential of the compounds. Immunocytochemistry, Western blotting, and ELISA techniques were employed to determine the levels of pro-inflammatory markers (NF-κB, RAGE, COX-1, COX-2, and PGE2) in THP-1 monocytes under in-vitro hyperglycemic conditions. RESULTS: Results indicate that the triazine derivatives 22, and 23 were the most potent antiglycation agents among the entire series, while non-toxic to HepG2, and THP-1 cells. Both compounds inhibited the AGEs-induced upstream and downstream signaling of NADPH oxidase and inflammatory mediators p38 and NF-κβ, respectively, in THP-1 monocytes. They also inhibited the induction of COX-2 and its product PGE2 by suppressing AGE-RAGE interactions. Moreover, compounds 22, and 23 reversed the AGEs-mediated suppression of COX-1 in THP-1 monocytes. CONCLUSION: In conclusion, 1,2,4-triazine derivatives 22, and 23 have the potential to suppress inflammatory responses under the diabetic environment through AGE-RAGE-NF-κβ/p38 nexus in THP-1 monocytes. These findings identify triazines 22, and 23 as compelling candidates for drug development, potentially beneficial for the diabetic patients with an elevated risk of vascular complications, such as atherosclerosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TriazinesGlycation End Products, AdvancedMonocytesReceptor for Advanced Glycation End ProductsDiabetes ComplicationsHumansTHP-1 CellsHep G2 CellsInflammationAnti-Inflammatory AgentsNF-kappa BSignal Transduction

Stichwörter der Autor:innen

1,2,4 triazine derivativesAdvanced glycation end productsCycloxygenase-2DiabetesInflammationMonocytesRAGEReactive oxygen species

Substanzen

TriazinesGlycation End Products, AdvancedReceptor for Advanced Glycation End Products1,2,4-triazineAnti-Inflammatory AgentsNF-kappa B

Autor:innen und Institutionen

  • Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan. Electronic address: humerajahan@iccs.edu.
  • Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan.
  • H. E. J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan.
  • Department of Molecular and Translational Medicine, University of Brescia, Brescia 25123, Italy.
  • Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan; H. E. J. Research Institute of Chemistry, Internat…

Förderung

  • Higher Education Commision, Pakistan
  • Higher Education Commission, Pakistan

Zitieren

APA

Jahan, H., Tufail, P., Shamim, S., Mohammed Khan, K., Gennari, M., Pizzi, M., & Iqbal Choudhary, M. (2024). 1,2,4-Triazine derivatives as agents for the prevention of AGE-RAGE-mediated inflammatory cascade in THP-1 monocytes: An approach to prevent inflammation-induced late diabetic complications. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113145

Vancouver

Jahan H, Tufail P, Shamim S, Mohammed Khan K, Gennari M, Pizzi M, et al. 1,2,4-Triazine derivatives as agents for the prevention of AGE-RAGE-mediated inflammatory cascade in THP-1 monocytes: An approach to prevent inflammation-induced late diabetic complications. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.113145

BibTeX
@article{Jahan2024,
  author = {Jahan, Humera and Tufail, Priya and Shamim, Shahbaz and Mohammed Khan, Khalid and Gennari, Michele and Pizzi, Marina and Iqbal Choudhary, M},
  title = {1,2,4-Triazine derivatives as agents for the prevention of AGE-RAGE-mediated inflammatory cascade in THP-1 monocytes: An approach to prevent inflammation-induced late diabetic complications},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.113145}
}
Kostenlos starten →